Guardant Health, Inc. GH
GH among the 162 companies we cover
Where it stands · the better end on the right. The band holds the middle half; the line is the median.
GH and 9 peers, year by year
The 9 Health care companies closest to GH in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.
Choose the peers
| Company | Year | Revenue | Sales growth | Gross margin | Operating margin | Net margin | FCF margin | Return on equity | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|
| GH Guardant Health, Inc. | FY2025 | $982.0M | +32.9% | - | −44.5% | −42.4% | −23.7% | n/m | n/m |
| SHC Sotera Health Co | FY2025 | $1.2B | +5.7% | 55.5% | - | 6.7% | 12.8% | 12.9% | 3.53 |
| TECH Bio-Techne | FY2026 | $1.2B | −0.4% | 65.8% | 20.7% | 15.0% | 21.7% | 8.6% | 0.09 |
| PGNY Progyny, Inc. | FY2025 | $1.3B | +10.4% | 23.6% | 6.6% | 4.5% | 14.9% | 11.3% | - |
| ACAD Acadia Pharmaceuticals Inc | FY2025 | $1.1B | +11.9% | - | 9.8% | 36.5% | 9.8% | 31.9% | - |
| HAE Haemonetics Corp | FY2026 | $1.3B | −2.0% | 59.0% | 11.7% | 7.3% | 19.5% | 12.2% | 1.56 |
| PBH Prestige Consumer Healthcare Inc. | FY2026 | $1.1B | −4.3% | 54.7% | 28.4% | 17.5% | 22.6% | 10.1% | 0.53 |
| MDGL Madrigal Pharmaceuticals, Inc. | FY2025 | $958.4M | +432% | - | −31.3% | −30.1% | −19.8% | −47.8% | 0.56 |
| ADUS Addus HomeCare Corp | FY2025 | $1.4B | +23.2% | 32.5% | 9.7% | 6.7% | 7.3% | 8.8% | 0.11 |
| LIVN LivaNova PLC | FY2025 | $1.4B | +10.7% | 67.7% | 14.4% | −17.5% | 12.5% | −20.2% | 0.31 |
Each company, year by year
Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL
Who rewrote the most
Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before
Revenue, FY2016 to FY2025
Revenue as reported in the 10-K.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | $25.2M | $49.8M | $90.6M | $214.4M | $286.7M | $373.7M | $449.5M | $563.9M | $739.0M | $982.0M |
| SHC Dec | - | - | - | $778.3M | $818.2M | $931.5M | $1.0B | $1.0B | $1.1B | $1.2B |
| TECH Jun | $499.0M | $563.0M | $643.0M | $714.0M | $738.7M | $931.0M | $1.1B | $1.1B | $1.2B | $1.2B |
| PGNY Dec | - | $48.6M | $105.4M | $229.7M | $344.9M | $500.6M | $786.9M | $1.1B | $1.2B | $1.3B |
| ACAD Dec | $17.3M | $124.9M | $223.8M | $339.1M | $441.8M | $484.1M | $517.2M | $726.4M | $957.8M | $1.1B |
| HAE Mar | - | $886.1M | $903.9M | $967.6M | $988.5M | $870.5M | $993.2M | $1.2B | $1.3B | $1.4B |
| PBH Mar | $806.2M | $882.1M | $1.0B | $975.8M | $963.0M | $943.4M | $1.1B | $1.1B | $1.1B | $1.1B |
| MDGL Dec | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $180.1M | $958.4M |
| ADUS Dec | $400.9M | $426.0M | $516.6M | $648.8M | $764.8M | $864.5M | $951.1M | $1.1B | $1.2B | $1.4B |
| LIVN Dec | $964.9M | $1.0B | $1.1B | $1.1B | $934.2M | $1.0B | $1.0B | $1.2B | $1.3B | $1.4B |
| Peer median | $499.0M | $494.5M | $579.8M | $714.0M | $764.8M | $870.5M | $993.2M | $1.1B | $1.2B | $1.2B |
Sales growth, FY2016 to FY2025
Revenue against the fiscal year before.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | - | +97.4% | +81.9% | +137% | +33.8% | +30.3% | +20.3% | +25.5% | +31.0% | +32.9% |
| SHC Dec | - | - | - | - | +5.1% | +13.9% | +7.8% | +4.5% | +4.9% | +5.7% |
| TECH Jun | - | +12.8% | +14.2% | +11.0% | +3.5% | +26.0% | +18.7% | +2.8% | +2.0% | +5.2% |
| PGNY Dec | - | - | +117% | +118% | +50.1% | +45.2% | +57.2% | +38.3% | +7.2% | +10.4% |
| ACAD Dec | n/m | +621% | +79.2% | +51.5% | +30.3% | +9.6% | +6.8% | +40.4% | +31.8% | +11.9% |
| HAE Mar | - | - | +2.0% | +7.0% | +2.2% | −11.9% | +14.1% | +17.7% | +12.0% | +4.0% |
| PBH Mar | - | +9.4% | +18.0% | −6.3% | −1.3% | −2.0% | +15.2% | +3.8% | −0.2% | +1.1% |
| MDGL Dec | - | - | - | - | - | - | - | - | - | +432% |
| ADUS Dec | - | +6.3% | +21.3% | +25.6% | +17.9% | +13.0% | +10.0% | +11.3% | +9.1% | +23.2% |
| LIVN Dec | - | +4.9% | +9.4% | −2.1% | −13.8% | +10.8% | −1.3% | +12.9% | +8.7% | +10.7% |
| Peer median | - | +9.4% | +18.0% | +11.0% | +4.3% | +11.9% | +12.1% | +12.1% | +7.9% | +10.4% |
Gross margin, FY2016 to FY2025
Gross profit / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | - | - | - | - | - | - | - | - | - | - |
| SHC Dec | - | - | - | 50.8% | 54.2% | 55.7% | 55.5% | 55.0% | 54.7% | 55.5% |
| TECH Jun | 67.5% | 66.5% | 67.2% | 66.3% | 65.4% | 68.0% | 68.4% | 67.7% | 66.4% | 64.8% |
| PGNY Dec | - | 15.2% | 18.4% | 19.8% | 20.3% | 22.4% | 21.3% | 21.9% | 21.7% | 23.6% |
| ACAD Dec | 82.2% | 92.7% | 94.5% | 96.7% | 97.7% | 97.8% | 98.0% | 94.3% | - | - |
| HAE Mar | - | 42.7% | 45.6% | 43.2% | 49.0% | 45.7% | 50.9% | 52.6% | 52.8% | 55.0% |
| PBH Mar | 57.9% | 56.7% | 55.4% | 56.9% | 57.3% | 58.0% | 57.1% | 55.4% | 55.5% | 55.8% |
| MDGL Dec | - | - | - | - | - | - | - | - | - | - |
| ADUS Dec | 26.5% | 27.2% | 26.5% | 27.6% | 29.6% | 31.2% | 31.5% | 32.1% | 32.5% | 32.5% |
| LIVN Dec | 58.0% | 64.4% | - | 66.8% | 63.7% | 68.2% | 69.2% | 65.5% | 68.1% | 67.7% |
| Peer median | 58.0% | 56.7% | 50.5% | 53.9% | 55.8% | 56.9% | 56.3% | 55.2% | 54.7% | 55.5% |
Operating margin, FY2016 to FY2025
Operating income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | −173.7% | −153.7% | −102.5% | −38.4% | −88.9% | −110.0% | −121.1% | −100.1% | −60.0% | −44.5% |
| SHC Dec | - | - | - | 23.6% | 25.2% | 27.6% | 24.7% | 26.4% | 27.0% | - |
| TECH Jun | 30.2% | 21.4% | 21.2% | 20.5% | 21.3% | 25.5% | 26.8% | 26.3% | 17.8% | 8.4% |
| PGNY Dec | - | −22.7% | −3.3% | 4.2% | 2.4% | 6.5% | 3.0% | 5.7% | 5.8% | 6.6% |
| ACAD Dec | n/m | −234.1% | −110.6% | −72.7% | −64.9% | −35.2% | −43.2% | −10.1% | 24.1% | 9.8% |
| HAE Mar | - | −2.2% | 6.2% | 8.6% | 10.5% | 10.3% | 8.1% | 13.4% | 12.6% | 16.3% |
| PBH Mar | 32.3% | 23.3% | 20.7% | 6.9% | 30.2% | 31.5% | 30.4% | −2.0% | 30.4% | 29.6% |
| MDGL Dec | - | - | - | - | - | - | - | - | −276.4% | −31.3% |
| ADUS Dec | 3.9% | 5.9% | 4.4% | 5.4% | 5.8% | 7.6% | 7.2% | 8.6% | 8.9% | 9.7% |
| LIVN Dec | 3.5% | 9.5% | −22.4% | −15.8% | −29.3% | −0.1% | −7.5% | −5.9% | 10.3% | 14.4% |
| Peer median | 17.0% | 5.9% | 4.4% | 6.1% | 8.1% | 9.0% | 7.7% | 7.2% | 12.6% | 9.8% |
Net margin, FY2016 to FY2025
Net income / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | −182.7% | −167.0% | −93.8% | −35.3% | −88.5% | −103.0% | −145.6% | −85.0% | −59.0% | −42.4% |
| SHC Dec | - | - | - | −2.7% | −4.7% | 12.5% | −23.3% | 4.9% | 4.0% | 6.7% |
| TECH Jun | 20.9% | 13.5% | 19.6% | 13.5% | 31.0% | 15.1% | 24.6% | 25.1% | 14.5% | 6.0% |
| PGNY Dec | - | −25.6% | 0.6% | −3.7% | 13.5% | 13.1% | 3.9% | 5.7% | 4.7% | 4.5% |
| ACAD Dec | n/m | −231.7% | −109.6% | −69.4% | −63.7% | −34.7% | −41.8% | −8.4% | 23.6% | 36.5% |
| HAE Mar | - | −3.0% | 5.0% | 5.7% | 7.7% | 9.1% | 4.4% | 9.9% | 9.0% | 12.3% |
| PBH Mar | 12.4% | 7.9% | 32.6% | −3.7% | 14.8% | 17.5% | 18.9% | −7.3% | 18.6% | 18.9% |
| MDGL Dec | - | - | - | - | - | - | - | - | −258.6% | −30.1% |
| ADUS Dec | 3.0% | 2.8% | 3.2% | 3.9% | 4.3% | 5.2% | 4.8% | 5.9% | 6.4% | 6.7% |
| LIVN Dec | −6.5% | −2.5% | −17.1% | −14.5% | −37.3% | −13.1% | −8.4% | 1.5% | 5.0% | −17.5% |
| Peer median | 7.7% | −2.5% | 3.2% | −3.2% | 6.0% | 10.8% | 4.1% | 5.3% | 6.4% | 6.7% |
Free cash flow, FY2016 to FY2025
Cash from operations minus capital spending.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | −$38.5M | −$78.9M | −$92.4M | −$65.9M | −$140.1M | −$284.1M | −$386.9M | −$345.5M | −$274.9M | −$233.1M |
| SHC Dec | - | - | - | $91.8M | $67.1M | $179.4M | $95.6M | −$362.7M | $45.1M | $149.2M |
| TECH Jun | $127.3M | $128.5M | $149.4M | $156.2M | $153.5M | $307.9M | $280.4M | $216.1M | $236.1M | $256.6M |
| PGNY Dec | - | −$10.1M | $1.7M | −$4.5M | $35.2M | $23.9M | $77.2M | $185.2M | $173.7M | $191.8M |
| ACAD Dec | −$209.9M | −$218.6M | −$169.6M | −$152.3M | −$143.8M | −$126.8M | −$114.0M | $16.7M | $157.2M | $105.1M |
| HAE Mar | $19.5M | $83.6M | $145.6M | $40.3M | $109.5M | $71.8M | $75.8M | $81.7M | $143.6M | $142.4M |
| PBH Mar | $172.7M | $145.7M | $197.6M | $178.8M | $202.6M | $213.4M | $250.3M | $221.9M | $239.4M | $243.3M |
| MDGL Dec | −$17.6M | −$22.4M | −$25.5M | −$41.8M | −$157.9M | −$184.1M | −$225.1M | −$325.7M | −$457.0M | −$190.0M |
| ADUS Dec | −$2.5M | $49.2M | $27.9M | $7.4M | $102.6M | $34.8M | $96.8M | $102.8M | $110.4M | $103.8M |
| LIVN Dec | $51.8M | $58.4M | $83.3M | −$115.8M | −$114.4M | $77.1M | $43.4M | $39.9M | $135.9M | $173.3M |
| Peer median | $19.5M | $53.8M | $55.6M | $7.4M | $67.1M | $71.8M | $77.2M | $81.7M | $143.6M | $149.2M |
FCF margin, FY2016 to FY2025
Free cash flow / revenue.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | −152.4% | −158.3% | −101.9% | −30.7% | −48.9% | −76.0% | −86.1% | −61.3% | −37.2% | −23.7% |
| SHC Dec | - | - | - | 11.8% | 8.2% | 19.3% | 9.5% | −34.6% | 4.1% | 12.8% |
| TECH Jun | 25.5% | 22.8% | 23.2% | 21.9% | 20.8% | 33.1% | 25.4% | 19.0% | 20.4% | 21.0% |
| PGNY Dec | - | −20.8% | 1.6% | −2.0% | 10.2% | 4.8% | 9.8% | 17.0% | 14.9% | 14.9% |
| ACAD Dec | n/m | −175.0% | −75.8% | −44.9% | −32.5% | −26.2% | −22.0% | 2.3% | 16.4% | 9.8% |
| HAE Mar | - | 9.4% | 16.1% | 4.2% | 11.1% | 8.2% | 7.6% | 7.0% | 11.0% | 10.5% |
| PBH Mar | 21.4% | 16.5% | 19.0% | 18.3% | 21.0% | 22.6% | 23.0% | 19.7% | 21.3% | 21.4% |
| MDGL Dec | - | - | - | - | - | - | - | - | −253.7% | −19.8% |
| ADUS Dec | −0.6% | 11.5% | 5.4% | 1.1% | 13.4% | 4.0% | 10.2% | 9.7% | 9.6% | 7.3% |
| LIVN Dec | 5.4% | 5.8% | 7.5% | −10.7% | −12.3% | 7.4% | 4.2% | 3.5% | 10.8% | 12.5% |
| Peer median | 13.4% | 9.4% | 7.5% | 2.7% | 10.6% | 7.8% | 9.7% | 8.4% | 11.0% | 12.5% |
Return on equity, FY2016 to FY2025
Net income / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | −57.9% | −27.0% | −17.6% | −9.5% | −19.5% | −59.7% | n/m | n/m | n/m | n/m |
| SHC Dec | - | - | - | n/m | −8.5% | 19.9% | −66.7% | 11.6% | 11.0% | 12.9% |
| TECH Jun | 11.9% | 8.0% | 11.7% | 8.2% | 16.6% | 9.0% | 16.0% | 14.5% | 8.1% | 3.8% |
| PGNY Dec | - | n/m | n/m | −7.5% | 27.8% | 26.1% | 8.1% | 11.2% | 12.9% | 11.3% |
| ACAD Dec | −52.4% | −86.3% | −51.2% | −33.7% | −44.9% | −31.0% | −53.9% | −14.2% | 30.9% | 31.9% |
| HAE Mar | −7.7% | −3.6% | 6.1% | 8.2% | 13.0% | 10.9% | 5.8% | 14.1% | 12.2% | 20.4% |
| PBH Mar | 13.4% | 8.4% | 28.8% | −3.3% | 12.2% | 12.1% | 13.0% | −5.7% | 12.6% | 11.7% |
| MDGL Dec | −72.5% | −17.1% | −6.9% | −20.2% | −84.3% | −123.3% | −149.6% | −92.2% | −61.8% | −47.8% |
| ADUS Dec | 7.9% | 7.0% | 6.1% | 5.3% | 6.4% | 7.9% | 7.3% | 8.8% | 7.6% | 8.8% |
| LIVN Dec | −3.7% | −1.4% | −12.6% | −11.4% | −31.4% | −10.5% | −7.1% | 1.4% | 4.8% | −20.2% |
| Peer median | −3.7% | −1.4% | 6.1% | −5.4% | 6.4% | 9.0% | 5.8% | 8.8% | 11.0% | 11.3% |
Debt / equity, FY2016 to FY2025
Total debt / shareholders' equity at the year end.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | - | - | - | - | - | - | - | - | n/m | n/m |
| SHC Dec | - | - | - | - | 4.03 | 2.97 | 5.55 | 5.02 | 5.49 | 3.53 |
| TECH Jun | 0.10 | 0.36 | 0.31 | 0.43 | 0.26 | 0.22 | 0.15 | 0.18 | 0.15 | 0.18 |
| PGNY Dec | - | - | n/m | - | - | - | - | - | - | - |
| ACAD Dec | - | - | - | - | - | - | - | - | - | - |
| HAE Mar | 0.57 | 0.43 | 0.34 | 0.52 | 0.65 | 0.97 | 1.03 | 0.94 | 0.84 | 1.49 |
| PBH Mar | 2.18 | 2.67 | 1.69 | 1.64 | 1.48 | 1.09 | 0.94 | 0.93 | 0.68 | 0.54 |
| MDGL Dec | - | - | - | - | - | 0.00 | 0.35 | 0.28 | 0.16 | 0.56 |
| ADUS Dec | 0.16 | 0.25 | 0.06 | 0.13 | 0.38 | 0.38 | 0.21 | 0.18 | 0.23 | 0.11 |
| LIVN Dec | 0.09 | 0.08 | 0.11 | 0.25 | 0.59 | 0.19 | 0.45 | 0.46 | 0.48 | 0.31 |
| Peer median | 0.16 | 0.36 | 0.31 | 0.43 | 0.62 | 0.38 | 0.45 | 0.46 | 0.48 | 0.54 |
EPS (diluted), FY2016 to FY2025
Diluted earnings per share, on today's share count after splits.
| Company | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| GH Dec | −$3.53 | −$7.07 | −$2.80 | −$0.84 | −$2.60 | −$4.00 | −$6.41 | −$4.28 | −$3.56 | −$3.32 |
| SHC Dec | - | - | - | −$0.09 | −$0.16 | $0.41 | −$0.83 | $0.18 | $0.16 | $0.27 |
| TECH Jun | $0.70 | $0.51 | $0.83 | $0.62 | $1.46 | $0.87 | $1.66 | $1.76 | $1.05 | $0.46 |
| PGNY Dec | - | −$2.37 | $0.04 | −$0.41 | $0.47 | $0.66 | $0.30 | $0.62 | $0.57 | $0.65 |
| ACAD Dec | −$2.34 | −$2.36 | −$1.94 | −$1.60 | −$1.79 | −$1.05 | −$1.34 | −$0.37 | $1.36 | $2.30 |
| HAE Mar | −$1.09 | −$0.51 | $0.85 | $1.04 | $1.48 | $1.55 | $0.84 | $2.24 | $2.29 | $3.31 |
| PBH Mar | $1.88 | $1.30 | $6.34 | −$0.69 | $2.78 | $3.25 | $4.04 | −$1.65 | $4.17 | $4.29 |
| MDGL Dec | −$5.07 | −$2.54 | −$2.22 | −$5.45 | −$13.09 | −$14.63 | −$17.23 | −$19.99 | −$21.90 | −$12.85 |
| ADUS Dec | $1.07 | $1.03 | $1.33 | $1.77 | $2.08 | $2.81 | $2.84 | $3.83 | $4.23 | $5.22 |
| LIVN Dec | −$1.28 | −$0.52 | −$3.91 | −$3.26 | −$7.18 | −$2.68 | −$1.61 | $0.32 | $1.16 | −$4.45 |
| Peer median | −$1.09 | −$0.52 | $0.43 | −$0.41 | $0.47 | $0.66 | $0.30 | $0.32 | $1.16 | $0.65 |
Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out GH and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more
Sources
Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.
Also
Financials: GH's own statements, year by year. Compare: the whole peer group on one page.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GH/export.csv") into a cell.